CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
47 hedge funds and large institutions have $80.2M invested in Carisma Therapeutics in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.2% less ownership
Funds ownership: 2.62% → 2.42% (-0.2%)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Holders
47
Holding in Top 10
1
Calls
$1.52M
Puts
$844K
Top Buyers
| 1 | +$2.53M | |
| 2 | +$1.78M | |
| 3 | +$1.67M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$978K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$388K |
Top Sellers
| 1 | -$5.12M | |
| 2 | -$3.76M | |
| 3 | -$1.8M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.53M |
| 5 |
AWS
AJ Wealth Strategies
New York
|
-$400K |